WITHDRAWN: The use of nanoparticles in LHRH receptor targeted therapy for cancer.
While chemotherapy remains the most effective means of treatment for cancer patients, it has become apparent that more efficient modalities are needed. As an alternative to current methods, which can often be toxic to healthy cells and tissues, we discuss "targeted therapy" as an alternate to conventional chemotherapy. We believe that the combination of nanoparticles bearing anticancer drugs with peptides used as targeting moieties should allow selective cytotoxic effects in tumors while sparing normal tissues from cytotoxicity.